Abstract. Sulforaphane (SFN) is an isothiocyanate that is found in abundant quantities in many cruciferous vegetables including broccoli and cauliflower. Its inhibitory effects on tumor cell growth in vitro and in vivo, which is dependent on the direct effect on cancer cells, has attracted considerable attention. This study examined the effects of SFN on the growth of human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells. The results showed that SFN inhibits the viability of both HeLa and HepG2 cells by inducing apoptosis, as evidenced by the formation of apoptotic bodies and the accumulation of the sub-G1 phase. RT-PCR and immunoblotting showed that treating the cells with SFN caused the down-regulation of anti-apoptotic Bcl-2 and Bcl-X L , and the up-regulation of pro-apoptotic Bax expression. SFN-induced apoptosis was associated with the proteolytic activation of caspase-3, and the degradation/cleavage of poly (ADP-ribose) polymerase and the ß-catenin protein. z-DEVDfmk, a caspase-3 specific inhibitor, blocked the activation of caspase-3 and increased the survival of the SFN-treated HeLa and HepG3 cells, suggesting that caspase-3 activation is essential for SFN-induced apoptosis.
Introduction
Apoptosis is a highly regulated process of programmed cell death that involves the activation of a series of molecular events, which is characterized by cell shrinkage, blebbing of the plasma membrane, and chromatin condensation that is consistent with DNA cleavage in the ladder (1, 2) . Apoptosis is a fundamental cellular activity that is essential for maintaining the physiological balance of an organism. It is involved in the immune defense machinery and plays an important role as a protective mechanism against carcinogenesis by eliminating damaged cells or the abnormal proliferation of cells (3) . Several genes have been identified to either induce or repress apoptosis. Caspases play a key role in the execution phase of cell death through various apoptotic stimuli (4) . These cysteine-related proteases are present in cells as inactive proenzymes, with the active tetramer being formed by the removal of the prodomain and cleavage between the large and small subunits. The caspase activity is responsible, either directly or indirectly, for the cleavage of several intracellular proteins, which are characteristically proteolysed during apoptosis (4) . The processing and activation of caspases can be regulated by molecules such as Bcl-2 as well as by members of the inhibitor of the apoptosis protein (IAP) family (5) . In most cases, apoptosis involves the release of cytochrome c from the mitochondria. In the cytosol, cytochrome c activates caspase-9, which in turn activates the effector caspases such as caspase-3. Bcl-2 and its related proteins control the release of cytochrome c from the mitochondria, whereas IAP molecules modulate the activity of caspases through a direct interaction with the active caspases (4, 5) . Accumulated data indicate that many chemotherapeutic agents can cause the death of tumor cells through the induction of apoptosis, which is the preferred way of managing cancer.
Many epidemiological studies have shown that the regular consumption of fruits and vegetables has an inhibitory effect on the development of cancer (6) . Therefore, it is important to identify the natural products of fruits and vegetables as well as to identify the molecular pathway(s) responsible for their effects on cancer cells. Isothiocyanates (ITCs) are widely distributed in cruciferous vegetables such as broccoli, cabbage, gardencress, cauliflower and Brussels sprouts (7) . Naturally occurring ITCs have significant chemopreventive activity against chemically induced cancer in animal models (8, 9 This study examined the antiproliferative activity of SFN along with its effect on the apoptosis of human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells. Furthermore, the levels of several important genes that are strongly associated with the signal transduction pathway of apoptosis were assayed to establish the anticancer mechanism of SFN as a potential chemopreventive agent.
Materials and methods
Cell culture and cell viability assay. Human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells were purchased from the American Type Culture Collection (Rockville, MD). Both cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 100 units/ml penicillin/streptomycin and supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco BRL, Gaithersburg, MD) at 37˚C and 5% CO 2 . The SFN was purchased from Sigma Chemical Co. (St. Louis, MO). A 20 mM concentration stock solution was made by dissolving SFN in dimethyl sulfoxide (DMSO). The solution was stored in aliquots at -20˚C. For the viability study, the cells were cultured in the presence or absence of various SFN concentrations for 48 h. The cells were trypsinized and washed with phosphate-buffered saline (PBS), and the viable cells were scored using a hemocytometer with trypan blue exclusion.
Nuclear staining with DAPI. The cells were washed with cold PBS and fixed with 3.7% paraformaldehyde in PBS for 10 min at room temperature. The fixed cells were washed with PBS, and stained with a 4,6-diamidino-2-phenylindile (DAPI, Sigma Chemical Co.) solution for 10 min at room temperature. The cells were washed twice more with PBS and analyzed by fluorescent microscopy (Carl Zeiss, Germany).
Flow cytometry assay of apoptosis. The DNA content of the cells was measured using a DNA staining kit (CycleTest™ Plus Kit, Becton-Dickinson, San Jose, CA). Propidium iodide (PI)-stained nuclear fractions were obtained using the instructions provided in the kit. The fluorescence intensity was determined using a FACScan flow cytometer and analyzed by CellQuest software (Becton-Dickinson). From the analysis of the DNA histograms, the percentage of cells in the different phases of the cell cycle was evaluated. Cells with a DNA content less than the G1 phase (sub-G1) were considered to be apoptotic.
RNA extraction and RT-PCR.
The total-RNA was prepared using an RNeasy kit (Qiagen, La Jolla, CA) and primed with random hexamers to synthesize the complementary DNA using AMV reverse transcriptase (Amersham Corp., Arlington Heights, IL) according to the manufacturer's instructions. The polymerase chain reaction (PCR) was carried out in a Mastercycler (Eppendorf, Hamburg, Germany) with the primers shown in Table I . The conditions used for the PCR reactions were 1 x (94˚C for 3 min); 35 x (94˚C for 45 sec; 58˚C for 45 sec; and 72˚C for 1 min) and 1 x (72˚C for 10 min). The amplification products obtained by PCR were separated electrophoretically on 1% agarose gel and visualized by ethidium bromide (EtBr) staining.
Gel electrophoresis and Western blot analysis.
The cells were harvested, lysed, and the protein concentrations were quantified using a Bio-Rad protein assay (Bio-Rad Lab., Hercules, CA) according to the manufacturer's instructions. Equal amounts of the protein were subjected to electrophoresis on SDSpolyacrylamide gels and transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH) by electroblotting. The blots were probed with the desired antibodies for 1 h, incubated with the diluted enzyme-linked secondary antibodies and visualized by enhanced chemiluminescence (ECL) according to the recommended procedure (Amersham Corp.). The primary antibodies were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA) and Calbiochem (Cambridge, MA). The peroxidase-labeled donkey anti-rabbit immunoglobulin and peroxidase-labeled sheep anti-mouse immunoglobulin were purchased from Amersham. Table I . Gene-specific primers for RT-PCR.
Assay of caspase-3 and caspase-9 activity. The enzymatic activity of the caspases induced by SFN was assayed using a colorimetric assay kit according to the manufacturer's instructions (R&D Systems, Minneapolis, MN). Briefly, the cells were lysed in a lysis buffer for 30 min on an ice bath. The lysed cells were centrifuged at 14,000 rpm for 10 min, and 100 μg of the protein was incubated with 50 μl of a reaction buffer and 5 μl of colorimetric tetrapeptides, Asp-Glu-ValAsp (DEVD)-p-nitroaniline (pNA) for caspase-3 and Leu-GluHis-Asp (LEHD)-pNA for caspase-9, respectively, at 37˚C for 2 h. The optical density of the reaction mixture was quantified spectrophotometrically at a wavelength of 405 nm.
Results

Growth inhibition of HeLa and HepG2 cells by SFN treatment.
The effects of SFN on the viability of HeLa and HepG2 cells were determined by treating the cells with different SFN concentrations and evaluating the cell viability using a trypan blue assay. As shown in Fig. 1 , SFN inhibited the viability of both cell lines in a concentration-dependent manner. After 48 h of treatment, SFN at 20 μM caused approximately 82% and 73% inhibition of cell growth in the HeLa and HepG2 cells compared with the controls, respectively.
Induction of apoptosis by SFN in HeLa and HepG2 cells. The
HeLa and HepG2 cells treated with SFN were examined after DAPI staining in order to determine if the growth inhibition by SFN was associated with apoptotic cell death. The control cells showed an intact nuclear structure, while the cells treated with SFN showed chromosomal condensation and the formation of apoptotic bodies in a concentration-dependent manner ( Figs. 2A and 3A) . The degree of apoptosis was quantified by analyzing the amount of sub-G1 DNA, which contained less DNA than the G1 cells, by flow cytometry of the fixed nuclei. As shown in Figs. 2B and 3B, the addition of SFN to the HeLa and HepG2 cells caused a marked increase in the accumulation of the sub-G1 phase. Overall, these results show that the growth inhibition observed in response to SFN is associated with the induction of apoptotic cell death.
Modulation of Bcl-2 family in SFN-treated HeLa and HepG2 cells. The apoptotic cascades involved by SFN in HeLa and
HepG2 cells were examined by exposing the cells to SFN and comparing the levels of the Bcl-2 family members. RT-PCR and Western immunoblotting showed that the transcriptional and translational levels of Bax expression, a pro-apoptotic gene, were partly induced in the SFN treated HeLa cells, whereas the levels of anti-apoptotic Bcl-2 and Bcl-X L in the HeLa cells were slightly inhibited in response to the SFN treatment (Fig. 4) . In HepG2 cells, the levels of Bax mRNA and protein expression were not affected in the SFN-treated cells. However, the levels of Bcl-2 and Bcl-X L expression were markedly down-regulated in response to the SFN treatment (Fig. 4) . 
Activation of caspase
SFN-treated HeLa and HepG2 cells was next examined by
Western blot analysis and an in vitro activity assay. The results showed that the SFN treatment down-regulated the levels of the pro-caspase-3 protein but the pro-caspase-9 levels remained unchanged in both cell lines (Figs. 5A and 6A) . In order to further quantify the proteolytic activation of caspase-3 and -9, the lysates equalized for protein from the cells treated with SFN were assayed for their caspase-3 and -9 activity using DEVD-pNA and LEHD-pNA as substrates, respectively. As shown in Figs. 5B and 6B, SFN increased the activity of caspase-3 in both HeLA and HepG2 cells in a concentration-dependent manner but had no effect on caspase-9. Furthermore, SFN induced the concomitant degradation and/or down-regulation of poly(ADP-ribose) polymerase (PARP) and ß-catenin, which are substrate proteins of caspase-3 (Figs. 5A and 6A).
Effects of SFN on the levels of IAP family.
On the other hand, the IAP family proteins bind to caspases, which lead to caspase inactivation in eukaryotic cells. Therefore, the involvement of the IAP family in the SFN-induced apoptosis of HeLa and HepG2 cells was further examined. The results showed that the levels of the IAPs family members such as XIAP, cIAP-1 and cIAP-2, remained unchanged or slightly down-regulated in the SFN-treated HeLa cells (Fig. 7) . The resulting cDNA was subjected to PCR with Bax, Bcl-2 and Bcl-X L primers. The reaction products were subjected to electrophoresis in 1% agarose gel and visualized by EtBr staining. GAPDH was used as the internal control. (B) The cells were lysed and the cellular proteins were then separated by SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. The membranes were probed with the anti-Bax, anti-Bcl-2 and anti-Bcl-X L antibodies. The proteins were visualized using an ECL detection system. Actin was used as the internal control. The proteins were visualized using an ECL detection system. Actin was used as the internal control. (B) After 48 h incubation with SFN, the aliquots were incubated with the substrates, DEVD-pNA and LEHD-pNA, to determine the in vitro caspase-3 and caspase-9 activity, respectively, at 37˚C forHowever, the levels of cIAP-1 expression were markedly inhibited in the SFN-treated HepG2 cells without altering the XIAP and cIAP-2 expression levels.
Inhibition of SFN-induced apoptosis by caspase-3 inhibitor.
In order to demonstrate that the activation of caspase-3 is a key step in the apoptotic pathway induced by SFN, HeLa and HepG3 cells were pretreated with z-DEVD-fmk (50 μM), a cell-permeable caspase-3 inhibitor, for 1 h, followed by a treatment with 20 μM SFN for 48 h. As shown in Fig. 8 , pretreatment of the cells with z-DEVD-fmk significantly blocked not only caspase-3 activation but also the increase in the sub-G1 population. These results clearly show that SFN-induced apoptosis is associated with the activation of caspase-3.
Discussion
Recently, there has been increasing interest in the use of isothiocyanate SFN as a cancer chemopreventive and a therapeutic agent. Many studies have reported that an SFN treatment caused the accumulation of cells in the G2/M phase of the cell cycle, suggesting that the growth inhibitory effect of SFN is the result of a block during the G2/M phase and that such cells do not enter the G1 phase (12, 14, 16, (18) (19) (20) . While the cell killing mechanism of SFN has been suggested (13, (15) (16) (17) (21) (22) (23) (24) , little is known about the effects of this compound on the growth of human cervical carcinoma and hepatocarcinoma cells. Therefore, this study investigated the The resulting cDNA was subjected to PCR with the indicated primers and the reaction products were subjected to electrophoresis in 1% agarose gel and visualized by EtBr staining. GAPDH was used as the internal control. (B) The cells were lysed and the cellular proteins were separated by SDSpolyacrylamide gels and transferred onto nitrocellulose membranes. The membranes were probed with the indicated antibodies. The proteins were visualized using an ECL detection system. Actin was used as the internal control. effects of SFN on the growth of human cervical carcinoma cells, HeLa and hepatocarcinoma HepG2 cells in order to examine the mechanisms of its anti-proliferative pathway. These results clearly show that SFN inhibits the cell viability and induces apoptosis in both HeLa and HepG2 cells, which appears to account for its anti-proliferating activity. The induction of apoptosis by SFN was confirmed by the characteristic morphological changes and the increase in the sub-G1 cells of the cell cycle (Figs. 2 and 3) .
Apoptosis is tightly regulated by a number of gene products that promote or block cell death at different stages. The Bcl-2 family is the most extensively studied and perhaps the most important (25, 26) . The caspase family also plays an important role in driving apoptosis. They are synthesized initially as single polypeptide chains representing the latent precursors that undergo proteolytic processing at specific residues to produce the subunits that form an active heterotetrameric protease (4, 27) . In mammals, members of the Bcl-2 family can be divided into two subfamilies; the anti-apoptotic protein family such as Bcl-2 and Bcl-X L , and the pro-apoptotic protein family such as Bax and Bak. These molecules either homodimerize or heterodimerize with the molecules with an opposing function (28) . Therefore, it was suggested that the ratio between the level of pro-apoptotic Bax protein and that of the anti-apoptotic factor, Bcl-2, determines if a cell responds to an apoptotic signal. It has recently become evident that the mitochondria play a key role in apoptosis (26) . Bax and adenine nucleotide translocator cooperate within the permeability transition pore complex to increase the mitochondrial membrane permeability, and discharge a number of apoptogenic molecules into the cytosol (29) . A well-known apoptogenic factor released from the permeabilized mitochondria is the respiratory component cytochrome c, which recruits the apoptosis protease activating factor (Apaf-1) and pro-caspase-9 to form apoptosomes. Caspase-9 is then activated, and orchestrates caspase-3 and other effector molecules for cell death (30) .
In addition, the IAP family members have been reported to have anti-apoptotic effects as a result of their function as direct inhibitors of activated caspases (3, 7 and 9), regulating cell cycle progression and modulating receptor-mediated signal transduction (5, 31) . Therefore, the down-regulation of IAPs relieves the triggering block of proapoptotic signaling and the execution caspases, thus activating cell death (3, 32) . Activated caspases induce limited proteolysis in many cellular proteins, which are degraded by the caspase family as a consequence of apoptosis, and have been used as markers of chemotherapy-induced apoptosis (33, 34) . In this study, SFNinduced apoptosis was accompanied by the down-regulation of Bcl-2/Bcl-X L and the selective down-regulation of IAP family members in HeLa and HepG2 cells (Figs. 4 and 7) . Moreover, the SFN treatment caused the activation of caspase-3 but not caspase-9 in a concentration-response manner. This is consistent with the degradation of PARP and the ß-catenin proteins, which are downstream targets of activated caspase-3 (Figs. 5 and 6 ). Under the same conditions, z-DEVD-fmk, a caspase-3 inhibitor, markedly prevented SFNinduced apoptosis by blocking caspase-3 activation (Fig. 8) . This suggests that caspase-3 play a key molecule in the apoptosis of U937 by SFN.
In summary, SFN induces apoptosis in HeLa cervical carcinoma and HepG2 hepatocarcinoma cells, which appears to account for its anti-proliferative activity. These apoptotic mechanisms were mediated by a modulation of the Bcl-2 family, the activation of caspase-3 and the selective downregulation of the IAP family. These results provide further information on the possible mechanisms for the anticancer activity of SFN.
